#USA #Sarasota #Hope Therapeutics #Zeta Surgical #Zeta TMS

ZETA SURGICAL Launches Zeta TMS Navigation System

In an exciting development for mental health treatment, ZETA SURGICAL in partnership with HOPE Therapeutics has successfully treated its first patient using the Zeta TMS Navigation System. This event, which took place at a HOPE Therapeutics clinic located in Sarasota, Florida, represents a significant milestone in improving treatment options for patients suffering from treatment-resistant depression and other neuropsychiatric disorders.

The Zeta TMS Navigation System, which is FDA-approved, is designed to provide non-invasive Transcranial Magnetic Stimulation (TMS) therapy. TMS is a highly effective treatment option for around one-third of patients experiencing major depressive disorder who do not respond to traditional medications. Additionally, TMS is being utilized for various other conditions, such as obsessive-compulsive disorder and other ailments associated with disrupted brain circuits.

At the heart of the Zeta TMS Navigation System is its proprietary RealTrack™ technology. This advanced system employs AI-driven computer vision to offer real-time, markerless imagery guidance during TMS procedures. Within two minutes, it can register a patient’s MRI or CT scan with their facial anatomy and continuously monitor the position of the TMS coil. The precision is striking, achieving sub-millimeter accuracy, thereby allowing clinicians to specifically target treatment areas in the brain.

As of now, HOPE Therapeutics has equipped its clinics in West Palm Beach and Sarasota with the Zeta TMS Navigation Systems. They are poised to begin TMS treatments utilizing this novel technology at both locations immediately. This strategic rollout aims to enhance the quality of care offered and expand access to personalized TMS interventions.

Raahil Sha, Co-Founder and Chief Technology Officer of ZETA, expressed his enthusiasm about this technology saying, “The commencement of patient treatments with the Zeta TMS Navigation System marks an important breakthrough in deploying surgical-grade accuracy to clinical settings for TMS therapy.” He further highlighted the impact that this technology can have on real patients, helping to address the pressing need for effective treatments in mental health care.

Dr. Rebecca Cohen, the Medical Director at HOPE Therapeutics, echoed this sentiment, stating that “the continuous advancement of precision TMS technology is reshaping the standards of psychiatric care. It inspires hope for increased accuracy and reliability in treatment, providing a personalized care experience that significantly improves patient outcomes.”

ZETA SURGICAL is pioneering a transformative approach in the field of image-guided surgery and targeted neurological therapeutics. Their navigation and robotics platform not only enhances the efficacy of TMS procedures but also broadens access to less invasive and highly precise targeted therapies across numerous medical contexts. The Zeta Navigation System and Zeta TMS Navigation System are both cleared by the FDA and are presently accessible across the United States.

As the landscape of psychiatric care evolves, the potential for advanced technologies such as the Zeta TMS Navigation System continues to grow. This revolutionary approach promises to redefine conventional treatment methods, thereby offering renewed hope to those affected by debilitating mental health conditions.

For further details, visit ZETA SURGICAL and HOPE Therapeutics.